Comparison of clinical efficacy between decitabine combined with half the amount of CAG regimen with CAG regimen alone in patients with inermediate to high-risk myelodysplastic syndrome
Publisher: Edp Sciences
E-ISSN: 2117-4458|8|issue|01024-01024
ISSN: 2117-4458
Source: Bio Web of conference, Vol.8, Iss.issue, 2017-01, pp. : 01024-01024
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract